These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Relationship of low-density lipoprotein particle size to plasma lipoproteins, obesity, and insulin resistance in Japanese men. Suehiro T; Ohguro T; Sumiyoshi R; Yasuoka N; Nakauchi Y; Kumon Y; Hashimoto K Diabetes Care; 1995 Mar; 18(3):333-8. PubMed ID: 7555476 [TBL] [Abstract][Full Text] [Related]
5. LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes. Wägner AM; Jorba O; Rigla M; Alonso E; Ordóñez-Llanos J; Pérez A Acta Diabetol; 2002 Dec; 39(4):215-20. PubMed ID: 12486496 [TBL] [Abstract][Full Text] [Related]
6. Anti-atherogenicity of soybean protein. Kanazawa T; Tanaka M; Uemura T; Osanai T; Onodera K; Okubo K; Metoki H; Oike Y Ann N Y Acad Sci; 1993 Mar; 676():202-14. PubMed ID: 8489132 [No Abstract] [Full Text] [Related]
7. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Tchernof A; Lamarche B; Prud'Homme D; Nadeau A; Moorjani S; Labrie F; Lupien PJ; Després JP Diabetes Care; 1996 Jun; 19(6):629-37. PubMed ID: 8725863 [TBL] [Abstract][Full Text] [Related]
8. LDL molecular size as risk factor in coronary artery disease. Kozma L; Fodor J; Chockalingam A; Sussex B Acta Med Hung; 1992-1993; 49(1-2):65-77. PubMed ID: 1296188 [TBL] [Abstract][Full Text] [Related]
9. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia. Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118 [TBL] [Abstract][Full Text] [Related]
10. [Small dense LDL concentration is closely associated with serum apolipoprotein B, comparisons of non-LDL cholesterol or LDL cholesterol]. Hayashi T; Hirano T; Shiobara T; Suguro T; Adachi M Rinsho Byori; 2006 Jun; 54(6):569-75. PubMed ID: 16872005 [TBL] [Abstract][Full Text] [Related]
11. Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial. Hummel J; Westphal S; Weber-Hamann B; Gilles M; Lederbogen F; Angermeier T; Luley C; Deuschle M; Kopf D J Clin Psychiatry; 2011 Jul; 72(7):885-91. PubMed ID: 21294998 [TBL] [Abstract][Full Text] [Related]
12. Beyond LDL cholesterol levels. Johns Hopkins Med Lett Health After 50; 2007 Jun; 19(4):7. PubMed ID: 17644849 [No Abstract] [Full Text] [Related]
13. Chemical precipitation of apolipoprotein B-containing lipoproteins facilitates determination of LDL particle size. Adler L; Hill JS; Frohlich J Clin Biochem; 2000 Apr; 33(3):187-90. PubMed ID: 10913516 [TBL] [Abstract][Full Text] [Related]
15. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes. Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863 [TBL] [Abstract][Full Text] [Related]
16. What is the best predictor of the atherogenic LDL subclass phenotype 'pattern B' in patients with type 2 diabetes mellitus? King RI; Florkowski CM; Yeo J; Walmsley TA; Shand BI; Scott RS; George PM Ann Clin Biochem; 2011 Mar; 48(Pt 2):166-9. PubMed ID: 21278248 [TBL] [Abstract][Full Text] [Related]
17. Association of low-density lipoprotein particle size and ratio of different lipoproteins and apolipoproteins with coronary heart disease. Biswas S; Ghoshal PK; Mandal SC; Mandal N J Cardiol; 2008 Oct; 52(2):118-26. PubMed ID: 18922385 [TBL] [Abstract][Full Text] [Related]
18. A nine-month, placebo-controlled study of the effects of growth hormone treatment on lipoproteins and LDL size in abdominally obese men. Svensson J; Bengtsson BA; Taskinen MR; Wiklund O; Johannsson G Growth Horm IGF Res; 2000 Jun; 10(3):118-26. PubMed ID: 10942632 [TBL] [Abstract][Full Text] [Related]
19. Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments. Lane DM; Alaupovic P; Knight-Gibson C; Dudley VS; Laughlin LO Am J Cardiol; 1995 Jun; 75(16):1124-9. PubMed ID: 7762498 [TBL] [Abstract][Full Text] [Related]
20. Fluvastatin lowers atherogenic dense low-density lipoproteins in postmenopausal women with the atherogenic lipoprotein phenotype. März W; Scharnagl H; Abletshauser C; Hoffmann MM; Berg A; Keul J; Wieland H; Baumstark MW Circulation; 2001 Apr; 103(15):1942-8. PubMed ID: 11306521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]